Fluorescent Antibody Techniques

Since its original discovery in 1942, immunofluorescence staining has remained a highly reliable and powerful technique for a wide range of research and diagnostic purposes.

Fluorescent Antibody

Image Credit: http://www.medicilon.com/fluorescent-antibody-technique/

In general, fluorescence antibody (FA) techniques will involve the use of cells or an antibody, whose constant region has been tagged with a fluorescent label otherwise known as a fluorophore. FA techniques are often categorized as either direct or indirect.

Direct FA

The direct FA technique, which can otherwise be referred to as direct immunofluorescence (DIF), involves the use of a single fluorescently labeled primary antibody that is used to bind to a target antigen. When used clinically, DIF is particularly useful for the rapid diagnosis of bacterial diseases like Streptococcus pyogenes, which is more commonly known as strep, as well as pneumonia that is the result of either Mycoplasma pneumoniae and Legionella pneumophilia species.

For such diagnostic purposes, the patient sample is first placed on a microscope slide and then exposed to the fluorescent antibody. Any binding between the fluorescent-tagged antibody and the target antigen, which for these situations would be bacteria, will cause these substances to illuminate upon examination with a fluorescence microscope.  

In addition to its use as a diagnostic tool, DIF is also widely used for scientific research studies. For such purposes, a frozen tissue sample that has been cut into 5 or 6 micrometers (µm) thin sections are placed onto a glass slide.

The slides are then incubated with a fluorescent-tagged antibody, which will typically include a panel of antibodies that are directed against IgA, IgG, and IgM antibody isotypes along with complement 3, that is targeted against the antigen of interest.

Note that the concentration of the antibody used for this type of study will be based on previous experiments that have confirmed which concentration can achieve the highest signal-to-background ratio.

After the slides have been incubated for at least 30 minutes in the dark and at room temperature, slides are washed and then imaged with a fluorescence microscope.

DFA

Image Credit: https://microbeonline.com/direct-fluorescent-antibody-dfa-test/

Indirect FA

As compared to the single-step technique used for DIF, indirect IF (IIF) or indirect FA (IFA) is a two-step process that begins with the application of an unlabeled primary antibody onto the sample that is directed against a target antigen. The second step of IIF involves the use of a fluorescent-labeled secondary antibody that is directed against the Fc portion of the primary antibody.

Although IIF is considered to be more complicated than DIF, as it takes longer to complete and requires the use of two compatible antibodies, it is superior in terms of its sensitivity capabilities.

Some common clinical applications of IFA tests include those used for the diagnosis of syphilis. For this type of IFA test, T. palladium cells that were previously isolated from a research animal is isolated and placed onto the surface of a glass slide. A serum that has been acquired from a patient is then spread over the T. palladium cells to allow for anti-treponemal antibodies, if they are present, to bind to the fixed antigens.

After the patient’s serum sample is washed away, a secondary antibody that has been tagged with a fluorophore is added. A positive syphilis result will illuminate all secondary antibody-fluorophore conjugate complexes.

Another type of IFA that is widely used in clinical settings is that which is used for the diagnosis of systemic lupus erythematosus (SLE). Patients with SLE, which is an autoimmune disease, will have an increased level of circulating anti-nuclear autoantibodies (ANA) that are targeted against both DNA and various proteins that bind to DNA.

For this type of IFA test, cells are cultured and then placed on a glass slide. Each slide is then incubated with a different concentration of the patient’s antibody, which is then washed to remove any unbound proteins.

After the wash step, a fluorescent-labeled secondary antibody, which for the ANA test will be antihuman IgG, is added to the slides and allowed to incubate. A titer of the ANA in the serum is then obtained from the highest serum dilution that showed fluorescence and used to determine an SLE diagnosis.

Flow cytometry

The third type of fluorescent antibody technique includes flow cytometry, which is an automated cell-counting system that can be used to quantify specific cells that are present in complex mixtures such as blood or serum.

A typical flow cytometry experiment will begin with the incubation of a fluorescently-labeled antibody that is targeted against a specific subpopulation of cells, such as anti-CD4, which can bind to the glycoprotein CD4 found on the surface of various immune cells including T helper cells, monocytes, and macrophages. Flow cytometry can also quantify the presence of multiple cell types by using appropriate cell makers.

After the incubation has been completed, the sample is then introduced to the flow cytometer. Within this machine, a narrow capillary force the cells present within the sample to move through in a single file. As the cells move through the capillary, a laser is used to activate and excite any cells that have been tagged with the fluorophore.

The fluorescence intensity of each excited cell is then measured by both forward- and side-scatter detectors and depicted on a histogram for analysis. Aside from quantification purposes, both flow cytometry and immunofluorescence can be used to sort cells into purified subpopulations for research purposes through a technique known as fluorescence-activated cell sorter (FACS).

References and Further Reading

Further Reading

Last Updated: Oct 20, 2020

Benedette Cuffari

Written by

Benedette Cuffari

After completing her Bachelor of Science in Toxicology with two minors in Spanish and Chemistry in 2016, Benedette continued her studies to complete her Master of Science in Toxicology in May of 2018. During graduate school, Benedette investigated the dermatotoxicity of mechlorethamine and bendamustine, which are two nitrogen mustard alkylating agents that are currently used in anticancer therapy.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cuffari, Benedette. (2020, October 20). Fluorescent Antibody Techniques. News-Medical. Retrieved on November 27, 2020 from https://www.news-medical.net/life-sciences/Fluorescent-Antibody-Techniques.aspx.

  • MLA

    Cuffari, Benedette. "Fluorescent Antibody Techniques". News-Medical. 27 November 2020. <https://www.news-medical.net/life-sciences/Fluorescent-Antibody-Techniques.aspx>.

  • Chicago

    Cuffari, Benedette. "Fluorescent Antibody Techniques". News-Medical. https://www.news-medical.net/life-sciences/Fluorescent-Antibody-Techniques.aspx. (accessed November 27, 2020).

  • Harvard

    Cuffari, Benedette. 2020. Fluorescent Antibody Techniques. News-Medical, viewed 27 November 2020, https://www.news-medical.net/life-sciences/Fluorescent-Antibody-Techniques.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.